Adam R. Kalbermatten - 28 Jul 2026 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Reporting relationship: Chief Commercial Officer
Issuer ticker: KRMD
Reported as of: 28 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Aug 2026, 16:11:30 UTC
Prior SEC filing: 13 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas Edward Adams - Attorney-in-Fact

Key filing fact

Adam R. Kalbermatten filed Form 4 for KORU Medical Systems, Inc. (KRMD) on 06 Aug 2026.

Key facts

This page summarizes Adam R. Kalbermatten's Form 4 filing for KORU Medical Systems, Inc. (KRMD).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 06 Aug 2026, 16:11.

Change

Previous filing in this sequence was filed on 13 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002080271 Primary reporting owner

KALBERMATTEN ADAM R

Relationship: Chief Commercial Officer
Address: C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH
Signature: /s/ Thomas Edward Adams - Attorney-in-Fact
Signature date: 06 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KRMD transaction

Common Stock

Options Exercise

Transaction value
Shares: +75,000
Change %: +24%
Price: $0.000000^*
Shares after: 387,500
Date: 28 Jul 2026
Ownership: Direct
Footnotes: F1

KRMD transaction

Common Stock

Tax liability

Transaction value
Shares: -25,483
Change %: -6.6%
Price: $4.26^*
Shares after: 362,017
Date: 28 Jul 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares of common stock delivered upon vesting of previously granted restricted stock units. Each restricted stock unit converts to one share of common stock upon vesting.

Footnote F2

Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

SEC remarks

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.